Jun 18, 2026 09:03AM
Jun 18, 2026 09:01AM
Jun 18, 2026 09:01AM
Jun 18, 2026 09:00AM
May 28, 2026 10:02AM
May 28, 2026 10:00AM
May 20, 2026 04:40PM Jaguar Health Reports First Quarter 2026 Financials
May 19, 2026 09:04AM
May 19, 2026 09:00AM
May 6, 2026 09:01AM
May 6, 2026 09:00AM
May 4, 2026 08:31AM
May 4, 2026 08:30AM
Apr 29, 2026 08:30AM Jaguar Health Announces Statistically Significant Results from Effectiveness Trial of Crofelemer (FDA Approved Canalevia-CA1) for Treatment of Chemotherapy-Induced Diarrhea in Dogs
Apr 13, 2026 08:32AM
Apr 13, 2026 08:30AM
Apr 8, 2026 08:32AM
Apr 8, 2026 08:30AM
Apr 7, 2026 08:30AM
Mar 18, 2026 09:01AM
Mar 18, 2026 09:00AM FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)
Mar 16, 2026 09:00AM
Mar 16, 2026 09:00AM
Mar 3, 2026 09:01AM
Mar 3, 2026 09:00AM
Feb 18, 2026 09:00AM
Jan 22, 2026 09:01AM
Jan 22, 2026 09:00AM Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi
Jan 14, 2026 09:00AM
Jan 12, 2026 09:00AM
Jan 12, 2026 09:00AM
Jan 6, 2026 09:04AM
Jan 6, 2026 09:00AM
Jan 2, 2026 09:00AM
Dec 15, 2025 09:02AM Jaguar Health submits abstract for crofelemer trial in short bowel syndrome
Dec 15, 2025 09:00AM
Dec 10, 2025 09:01AM
Dec 10, 2025 09:00AM
Dec 8, 2025 04:15PM
Dec 2, 2025 09:01AM
Dec 2, 2025 09:00AM
Nov 24, 2025 09:02AM Jaguar Health receives Australian patent for crofelemer in short bowel syndrome
Nov 24, 2025 09:00AM
Nov 20, 2025 09:00AM
Nov 17, 2025 08:00AM
Nov 14, 2025 09:00AM
Nov 6, 2025 09:00AM
Oct 24, 2025 04:15PM
Oct 6, 2025 09:01AM Jaguar Health meets with FDA on rare disease drug development
Oct 6, 2025 09:00AM

323,577 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All